These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8623792)

  • 1. Nicked free beta-subunit of human chorionic gonadotropin: a potential new marker for Down syndrome screening.
    Rotmensch S; Liberati M; Kardana A; Copel JA; Ben-Rafael Z; Cole LA
    Am J Obstet Gynecol; 1996 Feb; 174(2):609-11. PubMed ID: 8623792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.
    Krantz DA; Larsen JW; Buchanan PD; Macri JN
    Am J Obstet Gynecol; 1996 Feb; 174(2):612-6. PubMed ID: 8623793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results.
    Cheng PJ; Chu DC; Chueh HY; See LC; Chang HC; Weng DR
    Am J Obstet Gynecol; 2004 Feb; 190(2):442-7. PubMed ID: 14981387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome.
    Macri JN; Anderson RW; Krantz DA; Larsen JW; Buchanan PD
    Am J Obstet Gynecol; 1996 Feb; 174(2):566-72. PubMed ID: 8623786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome.
    Wenstrom KD; Owen J; Chu DC; Boots L
    Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Down syndrome screening performance using first-trimester serum markers.
    Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precise gaussian distribution functions of maternal serum alpha-fetoprotein and free beta-subunit of human chorionic gonadotropin for trisomy 21 screening: improved accuracy for patient counseling.
    Chik L; Spencer K; Johnson MP; Ayoub M; Krivchenia EL; Dombrowski MP; Sokol RJ; Evans MI
    Am J Obstet Gynecol; 1997 Oct; 177(4):882-6. PubMed ID: 9369839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High maternal serum free beta-hCG levels in Down syndrome pregnancies: a preliminary report.
    Hsu JJ; Ou YC; Chen KC; Hsieh TT; Soong YK
    Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):36-41. PubMed ID: 8935373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
    Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
    Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit.
    Kardana A; Cole LA
    Clin Chem; 1992 Jan; 38(1):26-33. PubMed ID: 1370771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay.
    Spencer K; Talbot JA; Abushoufa RA
    Prenat Diagn; 2002 Aug; 22(8):656-62. PubMed ID: 12210572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
    Hu Z; Liu X; Li L; Jia C; Li D; Liu R
    Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal screening for Down syndrome with maternal serum human chorionic gonadotropin levels.
    Petrocik E; Wassman ER; Kelly JC
    Am J Obstet Gynecol; 1989 Nov; 161(5):1168-73. PubMed ID: 2531546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
    Wenstrom KD; Owen J; Chu Dc; Boots L
    Am J Obstet Gynecol; 1999 Oct; 181(4):887-92. PubMed ID: 10521748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
    Borrell A; Mercade I; Casals E; Borobio V; Seres A; Soler A; Fortuny A; Cuckle H
    Ultrasound Obstet Gynecol; 2007 Dec; 30(7):941-5. PubMed ID: 18000942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin.
    Macri JN; Kasturi RV; Krantz DA; Cook EJ; Moore ND; Young JA; Romero K; Larsen JW
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1248-53. PubMed ID: 1699417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.